Trial · NCT04327843
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Tablets Routine Questionnaire (TRQ) | Change from Baseline to 6 month visit | Since participants stopped using oral medications once they were stable on LAI, there were only two participants remaining at 25 Week visit and therefore analysis was not done. As only 2 individuals were on concommittent oral CPD medication at 25 week follow up, mean change in TRQ was not calculated. This was just done to enter into clinical trials. | percentage of change in adherence | MEAN |
| PRIMARY | Long-Acting Injectable Adherence (LAI Adherence): Count of Participants Who Received All LAI Injections: | Baseline to 6 month visit | Poorly adherent patients with schizophrenia who received long-acting injectable antipsychotic medication and a customized adherence enhancement behavioral intervention (CAE-L). LAI injection frequency was 100%. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Drug Attitude Inventory (DAI) | Baseline to 6 month visit | Poorly adherent patients with schizophrenia who received long-acting injectable antipsychotic medication and a customized adherence enhancement behavioral intervention (CAE-L). | score on a scale | MEAN |
| SECONDARY | Brief Psychiatric Rating Scale (BPRS) | Baseline to 6 month visit | Poorly adherent patients with schizophrenia who received long-acting injectable antipsychotic medication and a customized adherence enhancement behavioral intervention (CAE-L). | score on a scale | MEAN |
| SECONDARY | Clinical Global Impressions (CGI) | Baseline to 6 month visit | Poorly adherent patients with schizophrenia who received long-acting injectable antipsychotic medication and a customized adherence enhancement behavioral intervention (CAE-L). | units on a scale | MEAN |
| SECONDARY | Social and Occupational Functioning Scale (SOFAS) | Baseline to 6 month visit | Poorly adherent patients with schizophrenia who received long-acting injectable antipsychotic medication and a customized adherence enhancement behavioral intervention (CAE-L). | score on a scale | MEAN |
| SECONDARY | Body Mass Index | Baseline to Month 6(week 25) | Poorly adherent patients with schizophrenia who received long-acting injectable antipsychotic medication and a customized adherence enhancement behavioral intervention (CAE-L). | kg/m^2 | MEAN |
| SECONDARY | ESRS-A Parkinsonism | Baseline to 6 months(25 weeks) | Poorly adherent patients with schizophrenia who received long-acting injectable antipsychotic medication and a customized adherence enhancement behavioral intervention (CAE-L). | score on a scale | MEAN |
| SECONDARY | ESRS-A Dystonia | Baseline to 6 months(25 weeks) | Poorly adherent patients with schizophrenia who received long-acting injectable antipsychotic medication and a customized adherence enhancement behavioral intervention (CAE-L). | score on a scale | MEAN |
| SECONDARY | ESRS-A Dyskinesia | Baseline to 6 months(25 weeks) | Poorly adherent patients with schizophrenia who received long-acting injectable antipsychotic medication and a customized adherence enhancement behavioral intervention (CAE-L). | score on a scale | MEAN |
| SECONDARY | ESRS-A Akathisia | Baseline to 6 months(25 weeks) | Poorly adherent patients with schizophrenia who received long-acting injectable antipsychotic medication and a customized adherence enhancement behavioral intervention (CAE-L). | score on a scale | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04327843/outcomes